secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001104659-24-065886
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio appoints Brendan P. O'Grady as new CEO effective May 29, 2024
----------------------------------------------------------------------

- Brendan P. O'Grady appointed CEO and director, effective May 29, 2024.
- Heather Mason transitions back to independent director role after serving as interim CEO since Jan 2024.
- O'Grady base salary $850,000 with 85% target bonus; receives 1.8M stock options and 500K RSUs as inducement.
- O'Grady previously CEO of Glenmark Global Formulations, CCO of Amwell, and CEO of Teva USA.
- Management continuity agreement provides severance of 2x base salary plus target bonus upon change-in-control termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000110465924065886/0001104659-24-065886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000110465924065886/tm2415496d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-065886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer